GTR 90714046
Bids Are Invited For Miscellaneous Medicines
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
90714046
Tendering Authority
Subscribe to view
Tender No
170/24/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Miscellaneous Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
05-02-2025
Closed
Work Detail
Pharmacological Group: Vasodilators And Sclerosants, Active Ingredient: Isosorbide Dinitrate, Pharmaceutical Form: Tablet, Concentration / Dosage: 10, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmaceutical Form: Sublingual Tablet, Concentration / Dosage: 5, Pharmacological Group: Thyroid Hormones And Thyroid Function Inhibitors, Active Ingredient: Levothyroxine Sodium, Concentration/Dosage: 100, Unit: Mcg, Concentration/Dosage: 25, Concentration/Dosage: 50, 12/30/2024, Pharmacological Group: Antihypertensives, Active Ingredient: Losartan Potassium, Concentration / Dosage: 50 Mg, Pharmacological Group: Hypoglycemic Agents, Active Ingredient: Metformin Hydrochloride, Concentration/Dosage: 500, Concentration/Dosage: 850, Pharmacological Group: Expectorants, Fluidifiers And Nasal Decongestants, Active Ingredient: N-Acetylcysteine, Pharmaceutical Form: Powder Granulated, Concentration / Dosage: 200, Volume: N/A, Presentation: Envelope, Accessory: N/A, Concentration / Dosage: 600, Presentation: N/A
Key Value
Tender Value
371,607 - BRL
Tender Documents
Global Tender Document
cc38d23e-f517-42e8-89ca-2eb2b2551c6d.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.